Point: Statins, plant sterol absorption, and increased coronary risk

Journal of Clinical Lipidology

Volumn 2, Issue 4, 2008, Pages 304-305

  Goldstein, Mark R ^a   Mascitelli, Luca ^b   Pezzetta, Francesca ^c  

^a Fountain Medical Court ^*  (United States)

^b Medical Service   (Italy)

^c Ospedale Civile di Tolmezzo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; COLESTIPOL; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PHYTOSTEROL; PLACEBO; SIMVASTATIN; STANOL ESTER;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID ABSORPTION; LIPID OXIDATION; MONOTHERAPY; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION;

EID: 48749133241     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.06.005     Document Type: Editorial

References (21)

1. Patel S.B. Plant sterols and stanols: their role in health and disease. J Clin Lipidol 2 (2008) S11-S19
2. Miettinen T.A., Gylling H., Strandberg T., Sarna S., and Finnish 4S Investigators. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian Simvastatin Survival Study. BMJ 316 (1998) 1127-1130
3. Berge K.E., von Bergmann K., Lutjohann D., et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 43 (2002) 486-494
4. Miettinen T.A., and Gylling H. Synthesis and absorbtion markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Invest 33 (2003) 976-982
5. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
6. Miettinen T.A., Strandberg T.E., Gylling H., and Finnish Investigators of the Scandinavian Simvastatin Survival Study Group. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 20 (2000) 1340-1346
7. Miettinen T.A., and Gylling H. Vascular effects of diets, especially plant sterol ester consumption. J Am Coll Cardiol 51 (2008) 1562-1563
8. Gylling H., and Miettinen T.A. The effect of plant stanol- and sterol-enriched foods on lipid metabolism, serum lipids and coronary heart disease. Ann Clin Biochem 42 (2005) 254-263
9. Assmann G., Cullen P., Erbey J., Ramey D.R., Kannenberg F., and Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovas Dis 16 (2006) 13-21
10. Rajaratnam R.A., Gylling H., and Miettinen T.A. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 35 (2000) 1185-1191
11. Miettinen T.A., Railo M., Lepantalo M., and Gylling H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol 45 (2005) 1794-1801
12. Weingärtner O., Lütjohann D., Ji S., et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 51 (2008) 1553-1561
13. Plat J., Brzezinka H., Lütjohann D., Mensink R.P., and von Bergmann K. Oxidized plant sterols in human serum and lipid infusions as measured by combined gas-liquid chromatography-mass spectrometry. J Lipid Res 42 (2001) 2030-2038
14. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ 11 suppl 1 (2004) S12-S16
15. Superko H.R., and King S. Is lowering low-density lipoprotein an effective strategy to reduce cardiac risk?. Circulation 117 (2008) 560-568
16. Azen S.P., Mack W.J., Cashin-Hemphill L., et al. Progression of coronary artery disease predicts clinical coronary events: long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 93 (1996) 34-41
17. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
18. Patel M.D., and Thompson P.D. Phytosterols and vascular disease. Atherosclerosis 186 (2006) 12-19
19. Buchwald H., Varco R.L., Matts J.P., et al., POSCH Group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 323 (1990) 946-955
20. Drazen J.M., Jarcho J.A., Morrissey S., and Curfman G.D. Cholesterol lowering and ezetimibe. N Engl J Med 358 (2008) 1507-1508
21. Friedewald V.E., Ballantyne C.M., Nissen S.E., Shah P.K., and Roberts W.C. The Editor's roundtable: atherosclerosis regression. Am J Cardiol 101 (2008) 967-974